Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bodybuilding Health+ vs Measured

Bodybuilding Health+
Graded #35

Higher grade

vs+3
Measured
Graded #58

Lower grade

The verdict

Bodybuilding Health+ takes it — 78.1/100 to 75.1/100.

Bodybuilding Health+ grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The Bodybuilding.com fitness brand's new compounded-telehealth arm — genuinely cheap GLP-1 bundles (sema and tirz both down to $139/mo on the annual plan) sitting on top of a deep sermorelin/NAD+/peptide bench — solid value and honest FDA labeling, but brand-new, compounded, and final-sale, so it lands as a value runner-up rather than a top pick.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBodybuilding Health+ +2
88
86
Dose & formulationBodybuilding Health+ +7
84
77
Clinical oversightMeasured +13
74
87
Labs & monitoringBodybuilding Health+ +5
68
63
FulfillmentBodybuilding Health+ +11
78
67
Contract termsBodybuilding Health+ +21
62
41
Bodybuilding Health+ · left barMeasured · right bar

The numbers

MetricBodybuilding Health+Measured
WeighScore78.1/10075.1/100
GradeC+C
Scorecard rank#35#58
SemaglutideFrom $139/mo$119/mo (compounded)
TirzepatideFrom $139/mo$219/mo (compounded)
CoverageNot disclosedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Bodybuilding Health+

Graded #35 · C+

Strengths

  • Low, publicly listed bundle pricing — compounded semaglutide and tirzepatide both fall to $139/mo on the 12-month plan (first month $179 sema / $209 tirz)
  • Licensed brand extension of Bodybuilding.com (trademark relationship stated on-site), which lends familiarity vs. anonymous GLP-1 startups
  • Unusually broad menu under one login — GLP-1 plus NAD+ (injection or nasal), sermorelin (injection or sublingual ODT), ED/tadalafil, and a deep peptide catalog
  • Standard telehealth flow with clear FDA/compounding disclaimers — online intake reviewed by independent licensed providers, U.S. compounding-pharmacy fulfillment, free until a provider approves

Where it loses points

  • Compounded and not FDA-approved — not Wegovy/Ozempic or Zepbound/Mounjaro; the site itself states these have not been evaluated by the FDA for safety, effectiveness, or quality
  • Brand-new operator — Dynamo Group LLC launched the storefront around April 2026 with only a thin, mixed ~26-review Trustpilot record (cancellation and billing complaints)
  • All sales final — prescription products are non-returnable, the medical-consult fee is non-refundable, and there are no refunds for dissatisfaction or results
  • Pharmacy and provider network aren't named on the live consumer pages, no LegitScript seal we could verify on-site, and the catalog reaches into investigational Retatrutide and research-grade peptides
Measured

Graded #58 · C

Strengths

  • Membership includes 1:1 nutrition support and board-certified provider care
  • Both compounded (from $79/mo microdose, $119 semaglutide, $229 tirzepatide) and brand-name Wegovy/Zepbound
  • Insurance or cash-pay options for brand-name medications
  • Oral option available (Wegovy pill); cancel-anytime membership

Where it loses points

  • The headline $79 'GLP-1 Microdose' is a promotional rate off a $99 list price, is filed by the provider under longevity rather than weight loss, and is not a labelled therapeutic dose of either molecule
  • Branded plans are a $49/mo membership with the medication billed separately at $149 to $449/mo
  • The site never states which billing term its 'from' prices assume, though the terms allow monthly, quarterly, semi-annual and annual
  • No state count is published
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard